Skip to main content

06-06-2018 | Gastrointestinal cancers | ASCO 2018 | Video

Expert commentary: GI highlights including the PRODIGE 7, PRODIGE 24, and PREOPANC trials

ASCO expert Andrew Epstein gives his account of some of the key trial findings in  gastointestinal cancer from this year's meeting (9:05).

Please log in to get access to this content

More on this topic

image credits